We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Toxic Clumps of Alpha-Synuclein Disrupt Function in Parkinson's Disease Neurons

By LabMedica International staff writers
Posted on 21 Jun 2016
Neurodegenerative disease researchers have found that some symptoms of Parkinson's disease (PD) are caused by the deleterious effect of toxic clumps of alpha-synuclein on mitochondrial function.

The accumulation of misfolded alpha-synuclein amyloid fibrils leads to the formation of insoluble aggregates that have been implicated in several neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. More...
It has been exceedingly difficult to define the structure of alpha-synuclein fibrils due to their insolubility and complexity.

Alpha-synuclein accumulation and mitochondrial dysfunction have both been strongly implicated in the pathogenesis of PD, and the two appear to be related. Mitochondrial dysfunction leads to accumulation and oligomerization of alpha-synuclein, and increased levels of alpha-synuclein cause mitochondrial impairment, but the basis for this bidirectional interaction remains obscure.

Investigators at the University of Pittsburgh School of Medicine (PA, USA) worked with a well-established rodent model of PD to show how alpha-synuclein disrupted mitochondrial function. They reported in the June 8, 2016, online edition of the journal Science Translational Medicine that specific forms of wild-type alpha-synuclein, such as oligomeric and dopamine-modified forms, but not the monomeric or fibrillar forms, bound with high affinity to the mitochondrial receptor TOM20 (Mitochondrial import receptor subunit TOM20 homolog).

This binding disrupted import of proteins required for mitochondrial function and led to senescence of mitochondria, which showed reduced respiration and increased production of reactive oxygen species.

Examination of postmortem brain tissue from PD patients revealed an aberrant alpha-synuclein–TOM20 interaction in nigrostriatal dopaminergic neurons that was associated with loss of imported mitochondrial proteins, thereby confirming this pathogenic process in the human disease.

"It is really exciting that we have found a mechanism we can target to create new treatments for this devastating disease," said senior author Dr. J. Timothy Greenamyre, professor of neurology at the University of Pittsburgh School of Medicine. "Ultimately, the interaction between alpha-synuclein and TOM20 leads to neurodegeneration. The effects of alpha-synuclein on mitochondria are like making a perfectly good coal-fueled power plant extremely inefficient, so it not only fails to make enough electricity, but also creates too much toxic pollution."

Related Links:
University of Pittsburgh School of Medicine


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.